Comparing Two Methods for Treating Liver Cancer: IRE vs RFA
Author Information
Author(s): Xing Rong, Liu Yutong, Liu Yang, Jiang Haihong, Liu Chao, Du Jiru
Primary Institution: School of Medical Devices, Shanghai University of Medicine & Health Sciences
Hypothesis
Is irreversible electroporation (IRE) as effective and safe as radiofrequency ablation (RFA) for treating liver cancer?
Conclusion
IRE and RFA show similar effectiveness and safety in treating liver cancer.
Supporting Evidence
- Both IRE and RFA had ablation success rates of around 86% and 87%, respectively.
- The technical success rates were 96% for RFA and 99% for IRE.
- Recurrence rates were similar at 16% for both methods.
- Complication rates were 28% for RFA and 26% for IRE.
Takeaway
Doctors can use two methods, IRE and RFA, to treat liver cancer, and both work well and are safe.
Methodology
A meta-analysis of 37 studies comparing the efficacy and safety of IRE and RFA in liver cancer treatment.
Potential Biases
Potential bias due to the inclusion of cohort studies and the nature of surgical interventions.
Limitations
The studies included varied in quality and design, which may affect the overall conclusions.
Participant Demographics
Included patients with primary and metastatic liver cancer, with a total of 1,685 cases for RFA and 524 for IRE.
Statistical Information
P-Value
p<0.01
Confidence Interval
95% CI: 81–92%
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website